Yahya El Mir: Ziwig Biotech Achieves U.S. Certification for Endometriosis Saliva Test – The Business Journal
The Business Journal shared a post on LinkedIn:
” [HEALTH] Ziwig Biotech Achieves U.S. Certification for Endometriosis Saliva Test.
One year after its deployment in France, the Lyon-based biotech (100 employees) will launch its test in the United States.
The product: ‘Ziwig Endotest‘, the first saliva test for the early diagnosis of endometriosis, which affects between 10 and 15% of women of childbearing age worldwide.
A flawless run in France:
- Reimbursed by the Health Insurance (~800€/test)
- 100 partner expert centres
- 22,500 patients benefiting in 2026
The test was awarded the Prix Galien International 2024 in the ‘Best Medical Technology’ category.
Partnership imminent: ‘We are conducting negotiations with several major laboratories. An agreement should be signed in the coming weeks,’ says Yahya EL MIR, founder.
Next stop: Germany.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 21, 2026, 17:57Ula Sankowska: What I’ll Bring to ASRM INNOVATE in Baltimore
-
Oct 21, 2026, 17:40Robert Borowczyk: The Invisible Waiting Room
-
Oct 21, 2026, 17:35Fereshteh Safian: Behind the Scenes of Reproductive Medicine
-
Oct 21, 2026, 17:20The Relationship Between Trophectoderm Biopsy and Early Pregnancy Outcomes – RBMO
-
Oct 21, 2026, 17:09Jules McDonald: The Future of Fertility Is Happening in Abu Dhabi
-
Oct 21, 2026, 16:53Ashley Evans: I Never Imagined I’d Be a Fertility Story with a Group of People Whom I Have Never Met…
-
Oct 21, 2026, 16:41Karthik Raj: Asherman’s Syndrome – When the Endometrium Cannot Regenerate Normally
-
Oct 21, 2026, 16:36Katy Encalade: A Few Misconceptions I Think Every Woman Considering Egg Donation Deserves to Understand
-
Oct 21, 2026, 16:21The FeRGI Working Group 2026-2027 – ESHRE SIG Reproductive Genetics